Dolasetron (DLT)
Dolasetron is a serotonin 5-HT3 receptor antagonist used to treat nausea and vomiting following chemotherapy. Its main effect is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata. It does not have much antiemetic effect when symptoms are due to motion sickness. This drug does not have any effect on dopamine receptors or muscarinic receptors. Dolasetron breaks down slowly, staying in the body for a long time. One dose usually lasts 4 to 9 hours and is usually administered once or twice daily. This drug is removed from the body by the liver and kidneys. Dolasetron is a well-tolerated drug with few side effects. Headache, dizziness, and constipation are the most commonly reported side effects associated with its use. There is a potential for prolonging of the QT interval to occur as well.

Organism species: Pan-species (General)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Complete Antigen of Dolasetron (DLT) Antigenic Transformation Customized Service Offer
Antibodies n/a Monoclonal Antibody to Dolasetron (DLT) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Dolasetron (DLT) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Dolasetron (DLT) CLIA Kit Customized Service Offer
n/a ELISA Kit for Dolasetron (DLT) ELISA Kit Customized Service Offer